Adial pharmaceuticals announces positive in-vivo non-clinical data with purnovate's pnv-6005 as a potential treatment for ulcerative colitis

Pnv-6005 significantly reduced both weight loss and colon damage in ulcerative colitis animal model pnv-6005 significantly reduced both weight loss and colon damage in ulcerative colitis animal model

ADIL Ratings Summary

ADIL Quant Ranking